| |
 Joe Dunne, Ph.D
Chairman of the Board
Dr. Dunne has been a director of Forbes Medi-Tech since November 2000 and was appointed Chairman of the Board in May 2008. Dr. Dunne was Chairman of the Board and CEO of Westgate Biological Ltd., a startup company in the Health Sciences area from June 1999 to December 2003 and is now a continuing member of the Board of Westgate. Dr. Dunne has had a distinguished career in the multi-million dollar food ingredient industry. During his career, Dr. Dunne served as the President of Cultor Food Science from 1997 to 1999 with responsibility for global manufacturing and research & development as well as a worldwide network of sales offices and distributors. As President of Quest (Food) International from 1993 to 1997, Dr. Dunne managed the company's Flavor and Food Ingredient activities in the USA, Canada and Mexico. Educated in Ireland, Dr. Dunne holds a B.Sc. and Ph.D. in Biochemistry from University College, Dublin and was a Postdoctoral Fellow at the University of California in San Diego and at the Max Planck Institute in Dortmund, West Germany.
 Charles A. Butt, B.Comm.
President and Chief Executive Officer
Charles Butt has extensive international and North American experience in business management, marketing and sales in the healthcare industry. Prior to joining Forbes as Senior Vice President, Mr. Butt served as President of The Charson Group Inc., a healthcare consulting company, specializing in strategic planning and new product introductions, based in Toronto. Before moving into consulting, Mr. Butt headed up the Consumer Health Products Division for Lederle Laboratories (Canada), where he was responsible for the initiation and development of the Consumer Health Products Group. Mr. Butt has also worked in a variety of marketing and sales roles at Shulton Inc. in Europe, Africa and the Middle East as well as Colgate-Palmolive (UK).
 Nitin Kaushal, BSc., CA
Director
Mr. Kaushal is the Head of Healthcare Investment Banking at Desjardins Securities in Toronto. He is a member of the Board of Directors of Victhom Human Bionics, Protox Therapeutics Genizon Biosciences. Prior to his current assignment, Mr. Kaushal was a Managing Director with Vengate Capital, a Life Sciences and Healthcare Investment Banking & Advisory Firm. Mr. Kaushal was a Managing Director at HSBC Securities in its Healthcare
Group and a Senior Investment Manager with MDS Capital Corp. Mr. Kaushal was awarded a Bachelor of Science (Chemistry) from the University of Toronto and is a Chartered Accountant.
 Greg Anderson
Director
Greg Anderson recently completed a 31-year career with the Johnson & Johnson Corporation, retiring as Vice-President, Human Resources for Janssen-Ortho Inc. in December 2006. He served on the Board of Directors for 26 years with three Johnson & Johnson affiliate companies, namely Ortho Pharmaceutical (Canada) Ltd., Ortho-McNeil Inc., and finally Janssen-Ortho Inc. He was a key leader in the management of two successful mergers and the resultant re-organizations. Greg Anderson graduated with a B.A. from Queen's University. He is also a Member of the Ontario Institute of Chartered Accountants.
| | 
| |
